Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Merck & Co (NY: MRK)
70.51 USD  +0.53 (+0.76%)
Streaming Delayed Price  /  Updated: 10:32 AM EDT, Sep 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,132,456
Open 70.35
Bid (Size) 70.51 (5)
Ask (Size) 70.52 (16)
Prev. Close 69.98
Today's Range 70.05 - 70.61
52wk Range 52.83 - 70.94
Shares Outstanding 2,690,303,898
Dividend Yield 2.71%
Performance
YTD
+25.42%
+25.42%
1 Month
+0.48%
+0.48%
3 Month
+15.06%
+15.06%
6 Month
+28.93%
+28.93%
1 Year
+6.91%
+6.91%
Top News
More News
Merck Publishes Corporate Responsibility Report
Report Illustrates How Merck Creates Sustainable Value for Business and Society Read More
from PR Newswire
How Copycat 'Biosimilars' Could Wrangle $60 Billion From Biotech Giants
Some $60 billion in sales are up for grabs as patents covering blockbusters from Amgen, AbbVie and Roche begin expiring. Read More
from Investor's Business Daily
More News
Read More
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Monotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Patients Whose Tumo
from Business Wire News Releases
PRESS DIGEST- British Business - Sept 18
category companyNews
from Reuters: Company News
Merck & Co Has Returned 21.4% Since SmarTrend Recommendation (MRK)
from Comtex SmarTrend® News Briefs
CytoDyn Inc.’s (CYDY) New HIV Treatment Could Bring a Paradigm Shift in HIV Therapy
from NetworkNewsWire
Watch for Shares of Merck & Co (MRK) to Approach Support at $69.09
from Comtex SmarTrend® News Briefs
RPT-FOCUS-Roche steps up efficiency drive to take sting out of biosimilars
category companyNews
from Reuters: Company News
Merck’s ZERBAXA® (ceftolozane and tazobactam) Met Primary Endpoints of Non-Inferiority Compared to Meropenem in Pivotal Phase 3 Study of Adult Patients with Hospital-Acquired Bacterial Pneumonia or Ve
from Business Wire News Releases
Noteworthy Thursday Option Activity: GOOGL, MRK, PI
category Stocks
from Market News Video
FOCUS-Roche steps up efficiency drive to take sting out of biosimilars
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.